Jiye Bio successfully completed the GMP production of 2000L Phase III clinical biopharmaceuticals in one go ——Laying the foundation for commercial production of innovative drugs for market launch|Jiye Bio—One stop CDMSO service platform for biological drug development, manufacture and sales.

Jiye Bio successfully completed the GMP production of 2000L Phase III clinical biopharmaceuticals in one go ——Laying the foundation for commercial production of innovative drugs for market launch

2024.11.08

On December 30, 2024, Jiye Bio successfully achieved GMP production of Phase III clinical samples for the JYB1904 project in a 2000L disposable bioreactor using advanced production technology and strict quality control system. All key quality parameters meet the requirements of clinical research for product quantity and quality.

This milestone achievement is a powerful proof of the company's R&D strength and production capacity, marking a decisive breakthrough in the industrialization process of innovative drugs, reaching new heights in new drug production capacity, and laying a solid foundation for the subsequent product launch and widespread application.

Jiye Bio has reached an important milestone in the construction of new factories and equipment validation, opening a new chapter in pharmaceutical production

Not have

Jiye Bio successfully completed the GMP production of 2000L Phase III clinical biopharmaceuticals in one go ——Laying the foundation for commercial production of innovative drugs for market launch

Hot News

Jiye Bio successfully passed the RAPT customer audit, taking international cooperation to a new level